Envista Holdings Corporation $NVST Stake Lifted by Lazard Asset Management LLC

Lazard Asset Management LLC lifted its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 703.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 78,927 shares of the company’s stock after acquiring an additional 69,099 shares during the quarter. Lazard Asset Management LLC’s holdings in Envista were worth $2,002,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NVST. Royal Bank of Canada boosted its stake in Envista by 26.6% during the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after purchasing an additional 4,885 shares in the last quarter. Millennium Management LLC raised its stake in shares of Envista by 218.6% in the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock worth $6,627,000 after buying an additional 263,442 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock worth $10,859,000 after buying an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Envista by 15.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after buying an additional 76,246 shares during the period. Finally, Prudential Financial Inc. lifted its holdings in shares of Envista by 22.1% in the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after buying an additional 3,395 shares during the period.

Envista Trading Up 0.3%

Shares of NVST opened at $27.39 on Monday. The business’s 50-day moving average price is $25.59 and its 200 day moving average price is $25.91. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $4.46 billion, a P/E ratio of 66.80, a P/E/G ratio of 1.55 and a beta of 0.86. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The company had revenue of $705.50 million during the quarter, compared to analyst estimates of $680.03 million. During the same period in the prior year, the firm earned $0.24 earnings per share. The business’s quarterly revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts expect that Envista Holdings Corporation will post 1.42 earnings per share for the current year.

Analysts Set New Price Targets

NVST has been the subject of several research reports. Morgan Stanley raised their target price on Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Robert W. Baird upped their price target on shares of Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. upped their price target on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Weiss Ratings lowered shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Finally, Citigroup assumed coverage on shares of Envista in a research note on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Envista presently has a consensus rating of “Hold” and an average target price of $28.62.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.